# Magnetically Enhanced Diffusion for Acute Ischaemic Stroke (MEDIS) Trial

Study · id `cardio:ct-nct03098732` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03098732](<https://clinicaltrials.gov/study/NCT03098732>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03098732

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 120 participants.

## Technical summary

Registry record NCT03098732. Randomized; double masking; primary purpose treatment. Start 2017-03-22 (actual); primary completion 2019-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT03098732, source copy `cardio:ctgov-nct03098732-2019-01-28`, retrieved 2026-10-26)
- Started: 2017-03-22 (actual) (ClinicalTrials.gov record NCT03098732, source copy `cardio:ctgov-nct03098732-2019-01-28`, retrieved 2026-10-26)
- Primary completion: 2019-12-31 (anticipated) (ClinicalTrials.gov record NCT03098732, source copy `cardio:ctgov-nct03098732-2019-01-28`, retrieved 2026-10-26)
- Completion: 2020-12-31 (anticipated) (ClinicalTrials.gov record NCT03098732, source copy `cardio:ctgov-nct03098732-2019-01-28`, retrieved 2026-10-26)
- Countries: United Kingdom (ClinicalTrials.gov record NCT03098732, source copy `cardio:ctgov-nct03098732-2019-01-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "SUSPENDED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03098732-2019-01-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: Magnetically Enhanced Diffusion for Acute Ischaemic Stroke (MEDIS) Trial
- Acronym: MEDIS
- Condition: Stroke, Acute
- Condition: Stroke, Ischemic
- Condition: Infarction, Middle Cerebral Artery
- Condition: Strokes Thrombotic
- Condition: Neurologic Disorder
- Condition: Cerebrovascular Disorders
- Condition: Intracranial Embolism and Thrombosis
- Intervention (Device): Magnetically Enhanced Diffusion (MED)
- Intervention (Device): MED Workstation Magnet Sham Control
- Lead sponsor: Pulse Therapeutics
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: 294f3d8b9597b457fef0fb86f39fa7788cd4dfe5df974cec480aef3da3095764
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
